|
Contents
|
|
|
|
|
Cho
YJ, Tsherniak A, Tamayo P, Santagata S, Ligon A, Greulich H, Berhoukim R,
Amani V, Goumnerova L, Eberhart CG, Lau CC, Olson JM, Gilbertson RJ, Gajjar
A, Delattre O, Kool M, Ligon K, Meyerson M, Mesirov JP, Pomeroy SL.
Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular
Subgroup That Drives Poor Clinical Outcome.
J Clin Oncol. 2010 Nov 22;. [Epub ahead of print
.JPG)
Abstract |
.gif)
Related articles
|
|
|
Craver
R, Sandquist D, Nadell J, Velez M.
Medulloblastoma variants and survival at a children's hospital.
Fetal Pediatr Pathol. 2011 Jan;30(1):53-9.
Abstract |
Related articles
|
|
|
Curran
EK, Le GM, Sainani KL, Propp JM, Fisher PG
Do
children and adults differ in survival from medulloblastoma? A study from
the SEER registry
J
Neurooncol. 2009 Oct;95(1):81-5. Epub 2009 Apr 25.
Abstract | .png)
Reprint
| Related articles
|
|
De Bortoli M, Castellino RC, Lu XY, Deyo J, Sturla
LM, Adesina AM, Perlaky L, Pomeroy SL, Lau CC, Man
TK, Rao PH, Kim JY.
Medulloblastoma outcome is adversely
associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of
chromosome 8.
BMC
Cancer. 2006 Sep 12;6(1):223 [Epub
ahead of print]
Abstract |
Reprint
|
|
Fernandez-Teijeiro A, Betensky RA, Sturla LM, Kim JY, Tamayo P, Pomeroy SL
Combining
Gene Expression Profiles and Clinical Parameters for Risk Stratification in
Medulloblastomas
Journal
of Clinical Oncology, Vol 22, No 6 (March 15), 2004: pp. 994-998
|
|
Paul Graham Fisher, Peter C. Burger, Charles G.
Eberhart
Biologic Risk
Stratification of Medulloblastoma: The Real Time Is Now
Journal of
Clinical Oncology, Vol 22, No 6
(March 15), 2004: pp. 971-974
|
|
Amar Gajjar, Roberto Hernan, Mehmet Kocak,
Christine Fuller, Youngsoo Lee, Peter J.
McKinnon, Dana Wallace, Ching Lau, Murali
Chintagumpala, David M. Ashley, Stewart J.
Kellie, Larry Kun, Richard J. Gilbertson
Clinical,
Histopathologic, and Molecular Markers of Prognosis: Toward a New Disease
Risk Stratification System for Medulloblastoma
Journal of Clinical
Oncology, Vol 22, No 6 (March 15), 2004: pp. 984-993
|
|
A.
J. Gajjar, R. Hernan, C. Fuller, Y. Lee, M. Kocak, C. Lau, M. Chintagumpala,
D. Ashley, S. Kellie, R. Gilbertson
Molecular markers predictive of disease
outcome in medulloblastoma
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract
No. 420
|
|
|
Gupta T, Jalali R, Goswami S, Nair V, Moiyadi A, Epari S, Sarin R.
Early
Clinical Outcomes Demonstrate Preserved Cognitive Function in Children with
Average-Risk Medulloblastoma When Treated with Hyperfractionated Radiation
Therapy.
Int
J Radiat Oncol Biol Phys. 2012 Feb 16. [Epub ahead of print]
Abstract |
Related articles
|
|
C. Haberler, I. Slavc, T. Czech, E. Gelpi, H.
Heinzl,
H. Budka, C. Urban, M. Scarpatetti, G. Ebetsberger-Dachs, C. Schindler, N. Jones, A.
Klein-Franke, H. Maier, B. Jauk, A. Kiefer and J.A. Hainfellner
Histopathological prognostic factors in medulloblastoma: High expression of
survivin is related to unfavourable outcome
Eur J Cancer.
2006 Sep 25; [Epub ahead of print]
Abstract
|
|
|
Korshunov
A, Remke M, Werft W, Benner A, Ryzhova M, Witt H, Sturm D, Wittmann A, Schöttler
A, Felsberg J, Reifenberger G, Rutkowski S, Scheurlen W, Kulozik AE, von
Deimling A, Lichter P, Pfister SM.
Adult and Pediatric Medulloblastomas Are Genetically Distinct and Require
Different Algorithms for Molecular Risk Stratification
J Clin Oncol. 2010 May 17;. [Epub ahead of print]
Abstract
|
|
|
Lo KC, Ma C, Bundy BN, Pomeroy SL, Eberhart CG, Cowell JK
Gain of 1q is a potential univariate negative prognostic marker for
survival in medulloblastoma
Clin
Cancer Res. 2007 Dec 1;13(23):7022-8
Abstract
|
|
|
Mazloom
A, Zangeneh AH, Paulino AC
Prognostic
Factors after Extraneural Metastasis of Medulloblastoma
Int J Radiat Oncol Biol Phys. 2010
Feb 2. [Epub ahead of print]
Abstract
|
|
Pomeroy
SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim
JY,
Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore
C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis
DN, Mesirov JP, Lander ES, Golub TR
Prediction of
central nervous system embryonal tumour outcome based on gene expression
Nature. 2002 Jan 24;415(6870):436-42
|
|
|
Rodini CO, Suzuki DE, Saba-Silva N, Cappellano A, de Souza JE, Cavalheiro S,
Toledo SR, Okamoto OK.
Expression
analysis of stem cell-related genes reveal OCT4 as a predictor of poor
clinical outcome in medulloblastoma.
J Neurooncol.
2011 Jul 2. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Smoll NR.
Relative survival of childhood and adult medulloblastomas and primitive
neuroectodermal tumors (PNETs).
Cancer. 2011 Aug 11. [Epub ahead of
print]
Abstract |
Related articles
|
|
|
Adult
Patients
|
|
|
|
|
Chargari
C, Feuvret L, Levy A, Lamproglou I, Assouline A, Hemery C, Ghorbal L, Lopez
S, Tep B, G GB, Lang P, Laigle-Donadey F, Cornu P, Mazeron JJ, Simon JM
Reappraisal
of clinical outcome in adult medulloblastomas with emphasis on patterns of
relapse
Br
J Neurosurg. 2010 Aug;24(4):460-7
Abstract
|
|
|
Lai R
Survival of patients with adult medulloblastoma: a population-based study
Cancer. 2008 Apr
1;112(7):1568-74, Epub 2008 Feb 15.
Abstract
|
Reprint
| Related articles
|
|
|
Packer RJ, Vezina G
Management of and prognosis with medulloblastoma: therapy at a crossroads
Arch Neurol. 2008 Nov;65(11):1419-24
Abstract |
Reprint |
Related articles
|
|
|
Pfister S, Rea S, Taipale M, Mendrzyk F, Straub B, Ittrich C,
Thuerigen O, Sinn HP, Akhtar A, Lichter P
The histone acetyltransferase hMOF is frequently downregulated in primary
breast carcinoma and medulloblastoma and constitutes a biomarker for
clinical outcome in medulloblastoma
Int
J Cancer. 2007 Nov 30; [Epub ahead of print]
Abstract
|
|
|
Rieken
S, Gaiser T, Mohr A, Welzel T, Witt O, Kulozik AE, Wick W, Debus J, Combs SE
Outcome
and prognostic factors of desmoplastic medulloblastoma treated within a
multidisciplinary treatment concept
BMC Cancer.
2010 Aug 23;10(1):450. [Epub ahead of print]
Abstract | .png)
Full Text |
Reprint
|
|
|
Riffaud L, Saikali S, Leray E, Hamlat A, Haegelen C, Vauleon E, Lesimple T.
Survival
and prognostic factors in a series of adults with medulloblastomas.
J
Neurosurg. 2009 Sep;111(3):478-87.
Abstract |
Reprint |
Related articles
|
|
|
Sanders RP, Onar A, Boyett JM, Broniscer A,
Morris EB, Qaddoumi I, Armstrong GT, Boop FA, Sanford RA, Kun LE, Merchant
TE, Gajjar A.
M1 Medulloblastoma: high risk at any age
J Neurooncol.
2008 Aug 15. [Epub ahead of print]
Abstract
|
|
F.
Spreafico, M. Massimino, L. Gandola, S. Siena, G. Cefalo, E. Mazza, P.
Versari, G. Landonio, P. Pedrazzoli, F. Fossati-Bellani
Survival
results in adults treated for medulloblastoma
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
479
|
|
|
Genetic
Alterations
|
|
|
|
|
Raso
A, Mascelli S, Biassoni R, Nozza P, Kool M, Pistorio A, Ugolotti E,
Milanaccio C, Pignatelli S, Ferraro M, Pavanello M, Ravegnani M, Cama A,
Garrè ML, Capra V.
High levels of PROM1 (CD133) transcript are a potential predictor of poor
prognosis in medulloblastoma.
Neuro Oncol. 2011 Apr 12;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Desmoplastic
Variant
|
 
|
|
|
|
Leary SE, Zhou T, Holmes E, Geyer JR, Miller DC.
Histology
predicts a favorable outcome inyoung children with desmoplastic
medulloblastoma: A report from the children's oncology group.
Cancer. 2011 Jan
18. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Pediatric
Patients
|
|
|
|
|
Chen SH, Liu LY, Jaing TH, Tseng CK, Lin KL, Lui
TN.
Multivariate survival analysis of children with medulloblastoma--a
single-center experience
Pediatr
Hematol Oncol. 2008 Sep;25(7):647-54
Abstract
|
|
|
Faccion RS, Ferreira RM, Grabois MF, Fonseca TC, de Oliveira JA, Maia RC.
Lack
of Prognostic Significance of Survivin in Pediatric Medulloblastoma.
Pathol Oncol
Res. 2011 Jun 17. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Hoff
KV, Hinkes B, Gerber NU, Deinlein F, Mittler U, Urban C, Benesch M, Warmuth-Metz
M, Soerensen N, Zwiener I, Goette H, Schlegel PG, Pietsch T, Kortmann RD,
Kuehl J, Rutkowski S
Long-term outcome and clinical prognostic factors in children with
medulloblastoma treated in the prospective randomised multicentre trial
HIT'91
Eur
J Cancer. 2009 Feb 26. [Epub ahead of print]
Abstract
|
|
|
Pfister
S, Remke M, Benner A, Mendrzyk F, Toedt G, Felsberg J, Wittmann A, Devens F,
Gerber NU, Joos S, Kulozik A, Reifenberger G, Rutkowski S, Wiestler OD,
Radlwimmer B, Scheurlen W, Lichter P, Korshunov A.
Outcome prediction in pediatric medulloblastoma based on DNA copy-number
aberrations of chromosomes 6q and 17q and the MYC and MYCN loci
J Clin Oncol. 2009 Apr 1;27(10):1627-36. Epub 2009 Mar 2
Abstract
|
|
|
Rutkowski S, von Hoff K, Emser A, Zwiener I,
Pietsch T, Figarella-Branger D, Giangaspero F, Ellison DW, Garre ML,
Biassoni V, Grundy RG, Finlay JL, Dhall G, Raquin MA, Grill J.
Survival
and Prognostic Factors of Early Childhood Medulloblastoma: An International
Meta-Analysis.
J
Clin Oncol. 2010 Oct 12. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Verma S, Tavare C, Gilles F
Histologic Features and Prognosis in Pediatric Medulloblastoma
Pediatr Dev Pathol. 2008 Jan 17. [Epub ahead of print]
Abstract |
Reprint
| Related articles
|
|
Paul M. Zeltzer, James M. Boyett, Jonathan
L. Finlay, A. Lel Albright, Lucy B. Rorke, Jerrold
M. Milstein, Jeffrey C. Allen, Kenneth R. Stevens,
Philip Stanley, Hao Li, Jeffrey H. Wisoff,
J. Russell Geyer, Patsy McGuire-Cullen, James A.
Stehbens, Susan B. Shurin, Roger J. Packer
Metastasis Stage, Adjuvant Treatment, and Residual Tumor Are Prognostic
Factors for Medulloblastoma in Children: Conclusions From the Children's Cancer
Group 921 Randomized Phase III Study
Journal of Clinical Oncology, Vol 17, Issue 3 (March),
1999: 832
|
|
|
Radiation Therapy
|
|
|
|
|
Rieken S, Mohr A, Habermehl D, Welzel T, Lindel K, Witt O, Kulozik AE, Wick
W, Debus J, Combs SE.
Outcome
and Prognostic Factors of Radiation Therapy for Medulloblastoma.
Int
J Radiat Oncol Biol Phys. 2011 Feb 22. [Epub ahead of print]
Abstract |
Related articles
|
|
Pediatric
Patients
|
|
|
|
Sirachainan
N, Nuchprayoon I, Thanarattanakorn P, Pakakasama S, Lusawat A, Visudibhan A,
Dhanachai M, Larbcharoensub N, Amornfa J, Shotelersuk K, Katanyuwong K,
Tangkaratt S, Hongeng S.
Outcome of medulloblastoma in children treated with reduced-dose radiation
therapy plus adjuvant chemotherapy.
J Clin Neurosci. 2011 Feb 8;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Risk
stratification
|
|
|
|
|
McCabe
MG, Bäcklund LM, Leong HS, Ichimura K, Collins VP.
Chromosome 17 alterations identify good-risk and poor-risk tumors
independently of clinical factors in medulloblastoma.
Neuro Oncol. 2011 Feb 2;. [Epub ahead of print]
Abstract |
Reprint |
Related articles
|
|
|
Tamayo
P, Cho YJ, Tsherniak A, Greulich H, Ambrogio L, Schouten-van Meeteren N,
Zhou T, Buxton A, Kool M, Meyerson M, Pomeroy SL, Mesirov JP.
Predicting Relapse in Patients With Medulloblastoma by Integrating Evidence
From Clinical and Genomic Features.
J Clin Oncol. 2011 Feb 28;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
|
|
